Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide for Glucose Tolerance in Antipsychotic-Treated Patients
NCT01845259Phase 2Unknown
- Sponsor
- Psychiatric Centre Rigshospitalet
- Start
- Apr 2013
- Primary completion
- Mar 2016
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of liraglutide in impaired glucose tolerance (IGT), impaired fasting glucose (IFG), sponsored by Psychiatric Centre Rigshospitalet. Status: unknown.
02
Drugs
03
Conditions
impaired glucose tolerance (IGT)impaired fasting glucose (IFG)
Beyond the preview
Go deeper on NCT01845259.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01845259.